The blood-brain barrier (BBB) acts as one of the most protective and impeding barriers to be overcome for material delivery to the brain. In the case of treating different neurodegenerative diseases this can often make brain-targeted delivery of many neurotherapeutics exorbitantly challenging. However, a nasal to brain administration route involving the olfactory region offers an advantageous, brain-directed, fast drug transportation pathway that successfully circumvents the BBB. Hyperbranched polymers (HBP) are promising drug delivery vectors due to their structural flexibility and multi-functionality whereas choline and its derivatives are well-recognized for their potential absorption-enhancing properties. Hence, the main objectives of this ongoing study is to evaluate the possible role of a choline-based mucoadhesive hyperbranched polymeric nanocarriers in facilitating the nose-to-brain delivery. Further we will be able to study it as an experimental neurotherapeutic as well as to determine the precise brain-targeted drug delivery mechanism with a major focus on olfactory pathway following the drug’s intranasal (IN) administration compared to its simple solution.